Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances-Reference-Cited by-同舟云学术

Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances

Published:2008-04 Issue:2 Volume:21 Page:274-290
ISSN:0893-8512
Container-title:Clinical Microbiology Reviews
language:en
Short-container-title:Clin Microbiol Rev

Author:

Nichols W. Garrett¹²³⁴,Peck Campbell Angela J.¹²³⁴,Boeckh Michael¹²³⁴

Affiliation:

1. GlaxoSmithKline, London, United Kingdom

2. Program in Infectious Diseases and Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center

3. Children's Hospital and Regional Medical Center

4. University of Washington, Seattle, Washington

Abstract

SUMMARY Though several antivirals have been developed and marketed to treat influenza virus infections, the development of antiviral agents with clinical activity against other respiratory viruses has been more problematic. Here we review the epidemiology of respiratory viral infections in immunocompetent and immunocompromised hosts, examine the evidence surrounding the currently available antivirals for respiratory viral infections other than influenza, highlight those that are in the pipeline, and discuss the hurdles for development of such agents.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology

Link

https://journals.asm.org/doi/pdf/10.1128/CMR.00045-07

Reference244 articles.

1. Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo

2. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. 2006. Diagnosis and management of bronchiolitis. Pediatrics118:1774-1793.

3. Angeles Marcos, M., M. Camps, T. Pumarola, J. Antonio Martinez, E. Martinez, J. Mensa, E. Garcia, G. Penarroja, P. Dambrava, I. Casas, M. T. Jimenez de Anta, and A. Torres. 2006. The role of viruses in the aetiology of community-acquired pneumonia in adults. Antiviral Ther.11:351-359.

4. Arnold, J. C., K. K. Singh, S. A. Spector, and M. H. Sawyer. 2006. Human bocavirus: prevalence and clinical spectrum at a children's hospital. Clin. Infect. Dis.43:283-288.

5. Aslan, T., A. B. Fassas, R. Desikan, D. Siegel, N. Munshi, J. Mehta, S. Singhal, B. Barlogie, and E. Anaissie. 1999. Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy. Bone Marrow Transplant.24:505-509.

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenovirus IgG and respiratory syncytial virus IgG seroprevalence in chronic obstructive pulmonary disease;Indian Journal of Medical Sciences;2023-12-23

2. Epidemiología de las principales infecciones víricas estacionales;FMC - Formación Médica Continuada en Atención Primaria;2023-12

3. SARS-CoV-2 and Brain Health: New Challenges in the Era of the Pandemic;Microorganisms;2023-10-08

4. Prevalence and clinical presentation of EV-D68 infections in Kansas City children during the 2022 season;Diagnostic Microbiology and Infectious Disease;2023-09

5. Neurotropic SARS-CoV-2: Causalities and Realities;COVID-19 Pandemic, Mental Health and Neuroscience - New Scenarios for Understanding and Treatment;2023-03-08